Tabruyn SP - Search Results

1

The angiostatic 16K human prolactin overcomes endothelial cell anergy and promotes leukocyte infiltration via nuclear factor-kappaB activation.

Tabruyn SP, Sabatel C, Nguyen NQ, Verhaeghe C, Castermans K, Malvaux L, Griffioen AW, Martial JA, Struman I. Tabruyn SP, et al. Mol Endocrinol. 2007 Jun;21(6):1422-9. doi: 10.1210/me.2007-0021. Epub 2007 Apr 3. Mol Endocrinol. 2007. PMID: 17405903

2

The antiangiogenic factor 16K human prolactin induces caspase-dependent apoptosis by a mechanism that requires activation of nuclear factor-kappaB.

Tabruyn SP, Sorlet CM, Rentier-Delrue F, Bours V, Weiner RI, Martial JA, Struman I. Tabruyn SP, et al. Mol Endocrinol. 2003 Sep;17(9):1815-23. doi: 10.1210/me.2003-0132. Epub 2003 Jun 5. Mol Endocrinol. 2003. PMID: 12791771

3

Cathepsin D processes human prolactin into multiple 16K-like N-terminal fragments: study of their antiangiogenic properties and physiological relevance.

Piwnica D, Touraine P, Struman I, Tabruyn S, Bolbach G, Clapp C, Martial JA, Kelly PA, Goffin V. Piwnica D, et al. Mol Endocrinol. 2004 Oct;18(10):2522-42. doi: 10.1210/me.2004-0200. Epub 2004 Jun 10. Mol Endocrinol. 2004. PMID: 15192082 Free article.

4

The antiangiogenic factor, 16-kDa human prolactin, induces endothelial cell cycle arrest by acting at both the G0-G1 and the G2-M phases.

Tabruyn SP, Nguyen NQ, Cornet AM, Martial JA, Struman I. Tabruyn SP, et al. Mol Endocrinol. 2005 Jul;19(7):1932-42. doi: 10.1210/me.2004-0515. Epub 2005 Mar 3. Mol Endocrinol. 2005. PMID: 15746189

5

Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signature.

Olivier S, Close P, Castermans E, de Leval L, Tabruyn S, Chariot A, Malaise M, Merville MP, Bours V, Franchimont N. Olivier S, et al. Mol Pharmacol. 2006 May;69(5):1615-23. doi: 10.1124/mol.105.020479. Epub 2006 Feb 23. Mol Pharmacol. 2006. PMID: 16497877 Free article.

6

Prolactin/growth hormone-derived antiangiogenic peptides highlight a potential role of tilted peptides in angiogenesis.

Nguyen NQ, Tabruyn SP, Lins L, Lion M, Cornet AM, Lair F, Rentier-Delrue F, Brasseur R, Martial JA, Struman I. Nguyen NQ, et al. Among authors: tabruyn sp. Proc Natl Acad Sci U S A. 2006 Sep 26;103(39):14319-24. doi: 10.1073/pnas.0606638103. Epub 2006 Sep 14. Proc Natl Acad Sci U S A. 2006. PMID: 16973751 Free PMC article.

7

Molecular pathways of angiogenesis inhibition.

Tabruyn SP, Griffioen AW. Tabruyn SP, et al. Biochem Biophys Res Commun. 2007 Mar 30;355(1):1-5. doi: 10.1016/j.bbrc.2007.01.123. Epub 2007 Jan 30. Biochem Biophys Res Commun. 2007. PMID: 17276388 Review.

8

Intrinsic pro-angiogenic status of cystic fibrosis airway epithelial cells.

Verhaeghe C, Tabruyn SP, Oury C, Bours V, Griffioen AW. Verhaeghe C, et al. Among authors: tabruyn sp. Biochem Biophys Res Commun. 2007 May 11;356(3):745-9. doi: 10.1016/j.bbrc.2007.02.166. Epub 2007 Mar 16. Biochem Biophys Res Commun. 2007. PMID: 17382901 Free article.

9

A new role for NF-kappaB in angiogenesis inhibition.

Tabruyn SP, Griffioen AW. Tabruyn SP, et al. Cell Death Differ. 2007 Aug;14(8):1393-7. doi: 10.1038/sj.cdd.4402156. Epub 2007 Apr 27. Cell Death Differ. 2007. PMID: 17464324 No abstract available.

10

Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways.

Verhaeghe C, Remouchamps C, Hennuy B, Vanderplasschen A, Chariot A, Tabruyn SP, Oury C, Bours V. Verhaeghe C, et al. Among authors: tabruyn sp. Biochem Pharmacol. 2007 Jun 15;73(12):1982-94. doi: 10.1016/j.bcp.2007.03.019. Epub 2007 Mar 24. Biochem Pharmacol. 2007. PMID: 17466952

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters